LAKE FOREST, Illinois (News release) -- Pactiv Evergreen Inc has announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, related to its acquisition by Novolex for $18.00 per share in cash.

The transaction is anticipated to close in the second quarter of 2025, pending foreign antitrust approvals and other customary conditions. Upon completion, Pactiv Evergreen will transition to a privately held company, delisting from Nasdaq. The announcement was made on January 21, 2025.